^
BIOMARKER:

TET2 mutation

i
Other names: TET2, Tet Methylcytosine Dioxygenase 2, KIAA1546, Methylcytosine Dioxygenase TET2, Tet Oncogene Family Member 2, Probable Methylcytosine Dioxygenase TET2, MDS
Entrez ID:
Related biomarkers:
TET2 mutation
MDS
ruxolitinib
Sensitive: A2 - Guideline
TET2 mutation
AML
cytarabine
Sensitive: C2 – Inclusion Criteria
TET2 mutation
AML
azacitidine
Sensitive: C2 – Inclusion Criteria
TET2 mutation
MDS
azacitidine
Sensitive: C2 – Inclusion Criteria
TET2 mutation
MDS
pembrolizumab
Sensitive: C3 – Early Trials
TET2 mutation
AML
venetoclax
Sensitive: C3 – Early Trials
TET2 mutation
AML
cytarabine/daunorubicin liposomal formulation
Resistant: C3 – Early Trials
TET2 mutation
AML
quizartinib
Sensitive: C3 – Early Trials
TET2 mutation
T Cell Non-Hodgkin Lymphoma
lenalidomide
Resistant: C3 – Early Trials
TET2 mutation
AML
talazoparib
Sensitive: D – Preclinical